Skip to main content

Advertisement

Fig. 7 | Respiratory Research

Fig. 7

From: Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat

Fig. 7

Reasons given by pulmonologists for not treating with “mild” IPF in an international survey [48]. *p < 0.05. a. IPF was defined as “mild” by the physician. b. Physicians who monitored the majority of patients with IPF for > 4 months after diagnosis before initiating treatment. c. Physicians who initiated antifibrotic treatment within 4 months of diagnosis in the majority of patients with IPF. NICE, National Institute for Health and Care Excellence (in the UK). Data from survey of pulmonologist in Canada, France, Germany, Italy, Spain and the UK. Republished with permission of Respiration, from Identifying barriers to idiopathic pulmonary fibrosis treatment: a survey of patient and physician views, Maher et al., doi: https://doi.org/10.1159/000490667, 2018; permission conveyed through Copyright Clearance Center, Inc.

Back to article page